Abbott India

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE358A01014
  • NSEID: ABBOTINDIA
  • BSEID: 500488
INR
28,857.00
30.15 (0.1%)
BSENSE

Dec 05

BSE+NSE Vol: 8.87 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 9.57% vs 7.30% in Sep 2024

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 13.76% vs 13.83% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 14.19% vs 12.79% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is 154.67% vs -18.86% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Abbott India With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
3,495.50
4,914.20
-1,418.70
-28.87%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,495.50
4,914.20
-1,418.70
-28.87%
Raw Material Cost
308.77
1,182.96
-874.19
-73.90%
Purchase of Finished goods
1,602.11
206.35
1,395.76
676.40%
(Increase) / Decrease In Stocks
-31.91
5.33
-37.24
-698.69%
Employee Cost
326.99
930.59
-603.60
-64.86%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
341.78
1,197.81
-856.03
-71.47%
Total Expenditure (Excl Depreciation)
2,547.74
3,523.04
-975.30
-27.68%
Operating Profit (PBDIT) excl Other Income
947.76
1,391.16
-443.40
-31.87%
Other Income
142.79
217.95
-75.16
-34.48%
Operating Profit (PBDIT)
1,090.55
1,609.11
-518.56
-32.23%
Interest
13.37
25.54
-12.17
-47.65%
Exceptional Items
0.00
111.26
-111.26
-100.00%
Gross Profit (PBDT)
1,077.18
1,597.86
-520.68
-32.59%
Depreciation
38.12
117.48
-79.36
-67.55%
Profit Before Tax
1,039.06
1,480.38
-441.32
-29.81%
Tax
257.93
134.46
123.47
91.83%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
781.13
1,345.92
-564.79
-41.96%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
96.97
-96.97
-100.00%
Net Profit
781.13
1,442.89
-661.76
-45.86%
Equity Capital
21.25
23.91
-2.66
-11.13%
Face Value
10.00
2.00
0.00
Reserves
0.00
13,640.87
-13,640.87
-100.00%
Earnings per share (EPS)
367.59
120.69
246.90
204.57%
Diluted Earnings per share
367.59
120.68
246.91
204.60%
Operating Profit Margin (Excl OI)
27.11%
28.31%
0.00
-1.20%
Gross Profit Margin
30.82%
32.52%
0.00
-1.70%
PAT Margin
22.35%
27.39%
0.00
-5.04%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 3,495.50 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 9.57% vs 7.30% in Sep 2024

Half Yearly - Standalone Net Profit
Standalone Net Profit 781.13 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 13.76% vs 13.83% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 947.76 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 14.19% vs 12.79% in Sep 2024

Half Yearly - Interest
Interest 13.37 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 154.67% vs -18.86% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.11%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024